新辅助 Cetuximab 在局部发达的唇状细胞癌中导致完整的病理反应
Ruba Alchaikh Hassan1, Zahra Gafarzadeh1, Shiva Salmasi2
1Internal Medicine, Eisenhower Health, Rancho Mirage, USA.
Cureus
|January 3, 2025
概括
这项案例研究表明,在PD-1抑制剂失效后,成功治疗高级白银唇状细胞癌 (SCC) 的新辅助 cetuximab 治疗. 这种方法为这种罕见的癌症提供了潜在的新治疗选择.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 双唇状细胞癌 (SCC) 是罕见的,通常被归类为皮肤性SCC (cSCC).
- 对于这种特定的亚型,标准的治疗方案尚未建立.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.7K
